Recruiting

1-Hour Premedication

Sponsor:

Paul Peng, MD PhD MSCR

Code:

NCT07268248

Conditions

Allergic Reaction to Contrast Media

Hypersensitivity Reaction

Computed Tomography

Premedication

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

IV glucocorticoid and antihistamine

IV glucocorticoid and antihistamine (standard of care)

Study Details

Brief summary:

1-hour Premedication for Allergy Goal in Emergency: PAGE-1 is a prospective, parallel, two-arm, non-inferiority, randomized controlled trial evaluating the safety of a 1-hour (intervention) versus a 4-hour (standard regimen) intravenous (IV) premedication protocol in adult patients in the Emergency Department (ED) with a documented iodinated contrast allergy and requiring computed tomography (CT) imaging for a high-risk indication.

Conditions

Allergic Reaction to Contrast Media

Hypersensitivity Reaction

Computed Tomography

Premedication

Study ID

NCT07268248

Start date

Sep 1, 2026

Status verified date

Feb, 2026

Completion date

Jan, 2029

Anticipated

Primary completion date

Dec, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Adult (≥ 21 years old)
2. Documented iodinated contrast allergy in the electronic health record
3. CT with iodinated contrast ordered for a high-risk indication, † defined as post-arrest, concern for aortic dissection, ischemia, occlusion, obstruction, or other life-threatening conditions requiring timely diagnosis
4. Willing and able to give consent

Exclusion Criteria:

1. Previous enrollment in this study
2. Pregnancy
3. Seafood or iodine allergy, alone
4. Gadolinium allergy

Study Design

Enrollment

540 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: 1-hour Premedication Protocol

IV glucocorticoid and antihistamine 1 hour before contrast

active comparator: 4-hour Premedication Protocol

IV glucocorticoid 4 hours before contrast and IV antihistamine 1 hour before contrast

Interventions

IV glucocorticoid and antihistamine

Methylprednisolone sodium succinate (e.g., Solu-Medrol®) 40 mg IV immediately plus diphenhydramine 25 mg IV 1 hour before contrast medium administration for CT imaging

IV glucocorticoid and antihistamine (standard of care)

Methylprednisolone sodium succinate (e.g., Solu-Medrol®) 40 mg IV immediately 4 hours before contrast medium administration, plus diphenhydramine 25 mg IV 1 hour before contrast for CT imaging

Primary outcome measure

  • Difference in proportion of Acute Contrast Reaction [ Time Frame: 30 minutes ]
  • Proportion of patients eligible for intervention [ Time Frame: Before randomization ]

Central Contacts and Locations

Central contacts

Locations

Rutgers, Robert Wood Johnson Hospital

Recruiting

New Brunswick, New Jersey, United States, 08901

Contacts

More Information

Sponsor

Paul Peng, MD PhD MSCR

Last update posted

Nov 18, 2026

Last verified

Feb, 2026

Keywords

  • Iodinated Contrast Reaction
  • Contrast-enhanced CT
  • Glucocorticoid prophylaxis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Paul Peng, MD PhD MSCR on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.